eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 20/01/2012
PIL Lucentis 10 mg/ml solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 19/09/2011 and displayed until 20/01/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to date of revision
Updated on 15/06/2011 and displayed until 19/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Changes to therapeutic indications
  • Change to MA holder contact details
Updated on 19/01/2011 and displayed until 15/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 18/11/2008 and displayed until 19/01/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 03/09/2008 and displayed until 18/11/2008
Reasons for adding or updating:
  • Change to packaging
Updated on 25/04/2008 and displayed until 03/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/02/2007 and displayed until 25/04/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ranibizumab